US2008221031A1PendingUtilityA1
Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
Est. expirySep 27, 2024(expired)· nominal 20-yr term from priority
A61P 7/00A61P 9/10A61P 7/02A61P 9/00A61P 7/04A61P 43/00A61K 38/57A61K 45/06A61K 31/195A61P 29/00A61K 38/55
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods, kits and compositions are described that include a non-naturally occurring kallikrein inhibitor and an anti-thrombolytic agent, e.g., an anti-fibrinolytic agent, for preventing or reducing blood loss and/or ischemia, e.g., ischemia associated with perioperative blood loss and cerebral ischemia, the onset of systemic inflammatory response, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia or a focal brain ischemia, e.g., in patients subjected to invasive surgical procedures, especially procedures requiring cardiopulmonary bypass.
Claims
exact text as granted — not AI-modified1 .- 28 . (canceled)
29 . A kit comprising a non-naturally occurring kallikrein inhibitor and tranexamic acid.Join the waitlist — get patent alerts
Track US2008221031A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.